Gordon Naylor
Chairman at MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Net worth: 693 296 $ as of 2024-02-28
Profile
Currently, Gordon Naylor is Non-Executive Chairman of Medical Developments International Ltd.
Mr. Naylor is also on the board of Orica Ltd.
and Seqirus Holdings UK Ltd.
and Senior Vice President & General Manager at CSL Plasma, Inc.
In the past Mr. Naylor held the position of Chief Financial Officer for CSL Ltd.
President of Seqirus UK Ltd.
and Co-Chief Financial Officer at CSL Behring LLC (both are subsidiaries of CSL Ltd.).
Mr. Naylor received an undergraduate degree from the University of Melbourne and an MBA from Melbourne Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-09-06 | 950,573 ( 1.10% ) | 510 648 $ | 2024-02-28 | |
ORICA LIMITED
0.00% | 2024-03-24 | 16,394 ( 0.00% ) | 182 649 $ | 2024-02-28 |
Gordon Naylor active positions
Companies | Position | Start |
---|---|---|
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Chairman | 2020-12-17 |
ORICA LIMITED | Director/Board Member | 2022-03-31 |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Part of CSL Ltd., Seqirus Holdings UK Ltd. is an investment holding private company. The company is based in Maidenhead, UK. Seqirus Holdings was founded in 2015. | Director/Board Member | 2015-05-28 |
Former positions of Gordon Naylor
Companies | Position | End |
---|---|---|
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Seqirus UK Ltd. manufactures vaccines. Its brands offer include Dukoral, Gardasil, Jespect, Menveo, Panvax, Rabipur, Vaqta, Benpen, Palexia, Rapivab, Tramal, and Versatis. The company was founded on July 31, 2015 and is headquartered in Maidenhead, the United Kingdom. | President | 2019-05-31 |
CSL LIMITED | Director of Finance/CFO | 2016-01-01 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Director of Finance/CFO | - |
Training of Gordon Naylor
Melbourne Business School | Masters Business Admin |
University of Melbourne | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
CSL LIMITED | Health Technology |
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
ORICA LIMITED | Process Industries |
Private companies | 4 |
---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Seqirus UK Ltd. manufactures vaccines. Its brands offer include Dukoral, Gardasil, Jespect, Menveo, Panvax, Rabipur, Vaqta, Benpen, Palexia, Rapivab, Tramal, and Versatis. The company was founded on July 31, 2015 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Part of CSL Ltd., Seqirus Holdings UK Ltd. is an investment holding private company. The company is based in Maidenhead, UK. Seqirus Holdings was founded in 2015. | Finance |